BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2637430)

  • 1. [Results of combined therapy in patients with nonseminomatous testicular tumors].
    Lalowicz I; Cieśla J; Kozaczka A; Poborski W; Rozek-Lesiak K; Machalski M
    Pol Tyg Lek; 1989 Jun 19-26; 44(25-26):603-6, 613. PubMed ID: 2637430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Surveillance" of non-seminomatous testicular tumors. A prospective study of 100 patients in the first stage of illness].
    Hornák M; Zvara V; Ondrus D
    Ann Urol (Paris); 1992; 26(5):306-10. PubMed ID: 1485800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT).
    Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V
    Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors and results of treating 42 patients with nln-seminomatous germ cell tumor of the testis].
    Czownicki Z; Rogozińska J; Choina B
    Pol Tyg Lek; 1996 Feb; 51(6-9):82-5. PubMed ID: 8756738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of stage I malignant non-seminoma tumors of the testis without systematic lumbo-aortic dissection. Results of a study begun 20 years ago. Apropos of 21 cases].
    Aubert J; Bon D; Dore B; Irani J
    Prog Urol; 1994 Jun; 4(3):349-56. PubMed ID: 7519099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, vinblastine and bleocin in the treatment of disseminated testicular cancer.
    Koynov KD; Tzekova VI; Velikova MT
    Int Urol Nephrol; 1993; 25(4):389-94. PubMed ID: 7506242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
    Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
    Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].
    Caty A; Depadt G; Feutry ML
    Bull Cancer; 1997 Aug; 84(8):796-9. PubMed ID: 9339184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate].
    van Veelen LR; Steyerberg EW; Cleton FJ; Keizer HJ
    Ned Tijdschr Geneeskd; 1999 Mar; 143(11):564-8. PubMed ID: 10321275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study of testicular tumors].
    Matsuki H; Ozono S; Arai K; Saka M; Cho M; Nakagawa Y; Kaneko Y; Yoshida K; Okamoto S; Maruyama Y
    Hinyokika Kiyo; 1988 Oct; 34(10):1757-65. PubMed ID: 2854363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testicular tumors: our follow-up and treatment protocol. Report of 30 cases].
    Lozano Ortega JL; Llarena Ibarguren R; Pertusa Peña C
    Arch Esp Urol; 1994 Sep; 47(7):657-69. PubMed ID: 7802469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of treatment following stage-dependent therapy of non-seminomatous testicular tumors].
    Tschochner HJ; Bockhorn V; John H; Katenkamp D; Kühnert M; Möller A; Müller HJ; Ruffert K; Stadie G; Stiller D
    Z Urol Nephrol; 1987 Oct; 80(10):587-93. PubMed ID: 3433987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testicular germ cell tumors: prognosis].
    Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
    Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term results of multimodality therapy of testicular germ cell tumor].
    Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.